-
Something wrong with this record ?
Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors
I. Poláková, O. Pelák, D. Thürner, B. Pokrývková, R. Tachezy, T. Kalina, M. Šmahel,
Language English Country Egypt
Document type Journal Article
NLK
Directory of Open Access Journals
from 1990
Free Medical Journals
from 2014
PubMed Central
from 2014
Europe PubMed Central
from 2014
ProQuest Central
from 2008-01-01
Open Access Digital Library
from 1990-01-01
Open Access Digital Library
from 2014-01-08
Open Access Digital Library
from 2014-01-01
Medline Complete (EBSCOhost)
from 2014-01-01
Health & Medicine (ProQuest)
from 2008-01-01
Wiley-Blackwell Open Access Titles
from 1990
ROAD: Directory of Open Access Scholarly Resources
from 2014
PubMed
30886872
DOI
10.1155/2019/6705949
Knihovny.cz E-resources
- MeSH
- Single-Cell Analysis MeSH
- Leukocyte Common Antigens immunology MeSH
- Deoxyribonuclease I metabolism MeSH
- Immunophenotyping methods MeSH
- Collagenases metabolism MeSH
- Humans MeSH
- Lymphocytes physiology MeSH
- Antibodies, Monoclonal metabolism MeSH
- Myeloid Cells physiology MeSH
- Neoplasms diagnosis immunology MeSH
- Palladium metabolism MeSH
- Flow Cytometry MeSH
- Cell Separation MeSH
- DNA Barcoding, Taxonomic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Monitoring immune responses to solid cancers may be a better prognostic tool than conventional staging criteria, and it can also serve as an important criterion for the selection of individualized therapy. Multiparametric phenotyping by mass cytometry extended possibilities for immunoprofiling. However, careful optimization of each step of such method is necessary for obtaining reliable results. Also, with respect to procedure length and costs, sample preparation, staining, and storage should be optimized. Here, we designed a panel of 31 antibodies which allows for identification of several subpopulations of lymphoid and myeloid cells in a solid tumor and peripheral blood simultaneously. For sample preparation, disaggregation of tumor tissue with two different collagenases combined with DNase I was compared, and removal of dead or tumor cells by magnetic separation was evaluated. Two possible procedures of barcoding for single-tube staining of several samples were examined. While the palladium-based barcoding affected the stability of several antigens, the staining with two differently labeled CD45 antibodies was suitable for cells isolated from a patient's blood and tumor. The storage of samples in the intercalation solution for up to two weeks did not influence results of the analysis, which allowed the measurement of samples collected within this interval on the same day. This procedure optimized on samples from patients with head and neck squamous cell carcinoma enabled identification of various immune cells including rare subpopulations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027708
- 003
- CZ-PrNML
- 005
- 20190823125924.0
- 007
- ta
- 008
- 190813s2019 ua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2019/6705949 $2 doi
- 035 __
- $a (PubMed)30886872
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ua
- 100 1_
- $a Poláková, Ingrid $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 245 10
- $a Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors / $c I. Poláková, O. Pelák, D. Thürner, B. Pokrývková, R. Tachezy, T. Kalina, M. Šmahel,
- 520 9_
- $a Monitoring immune responses to solid cancers may be a better prognostic tool than conventional staging criteria, and it can also serve as an important criterion for the selection of individualized therapy. Multiparametric phenotyping by mass cytometry extended possibilities for immunoprofiling. However, careful optimization of each step of such method is necessary for obtaining reliable results. Also, with respect to procedure length and costs, sample preparation, staining, and storage should be optimized. Here, we designed a panel of 31 antibodies which allows for identification of several subpopulations of lymphoid and myeloid cells in a solid tumor and peripheral blood simultaneously. For sample preparation, disaggregation of tumor tissue with two different collagenases combined with DNase I was compared, and removal of dead or tumor cells by magnetic separation was evaluated. Two possible procedures of barcoding for single-tube staining of several samples were examined. While the palladium-based barcoding affected the stability of several antigens, the staining with two differently labeled CD45 antibodies was suitable for cells isolated from a patient's blood and tumor. The storage of samples in the intercalation solution for up to two weeks did not influence results of the analysis, which allowed the measurement of samples collected within this interval on the same day. This procedure optimized on samples from patients with head and neck squamous cell carcinoma enabled identification of various immune cells including rare subpopulations.
- 650 _2
- $a monoklonální protilátky $x metabolismus $7 D000911
- 650 _2
- $a separace buněk $7 D002469
- 650 _2
- $a kolagenasy $x metabolismus $7 D017364
- 650 _2
- $a taxonomické DNA čárové kódování $7 D058893
- 650 _2
- $a deoxyribonukleasa I $x metabolismus $7 D003850
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunofenotypizace $x metody $7 D016130
- 650 _2
- $a antigeny CD45 $x imunologie $7 D017493
- 650 _2
- $a lymfocyty $x fyziologie $7 D008214
- 650 _2
- $a myeloidní buňky $x fyziologie $7 D022423
- 650 _2
- $a nádory $x diagnóza $x imunologie $7 D009369
- 650 _2
- $a palladium $x metabolismus $7 D010165
- 650 _2
- $a analýza jednotlivých buněk $7 D059010
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pelák, Ondřej $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
- 700 1_
- $a Thürner, Daniel $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
- 700 1_
- $a Pokrývková, Barbora $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Kalina, Tomáš $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic.
- 700 1_
- $a Šmahel, Michal $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 773 0_
- $w MED00186351 $t Journal of immunology research $x 2314-7156 $g Roč. 2019, č. - (2019), s. 6705949
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30886872 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823130138 $b ABA008
- 999 __
- $a ok $b bmc $g 1432857 $s 1066168
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 2019 $c - $d 6705949 $e 20190211 $i 2314-7156 $m Journal of immunology research $n J. immunol. res. $x MED00186351
- LZP __
- $a Pubmed-20190813